Study of Multiple Myeloma Patients Relapsing or Progressing After Autologous Transplantation on Total Therapy 2

NCT00573391 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped low accrual

Conditions

Multiple Myeloma

Interventions

DRUG: Velcade, Thalidomide, and Dexamethasone
DRUG: Velcade, Melphalan, and Dexamethasone

Sponsor

University of Arkansas